申请人:BIOCRYST PHARMACEUTICALS, INC.
公开号:US10905683B2
公开(公告)日:2021-02-02
Use of a compound of formula (I): wherein A, X, Y, R1 and R2 as defined herein, in treating hereditary angioedema is disclosed. A composition containing the compounds, a polar organic solvent or a mixture thereof; and optionally a co-solvent, is also disclosed.
本发明公开了一种式 (I) 的化合物:其中 A、X、Y、R1 和 R2 如本文所定义,用于治疗遗传性血管性水肿。还公开了一种含有化合物、极性有机溶剂或其混合物以及可选助溶剂的组合物。